@article{7e6dbf8a2c274971a35a1495f44a00d5,
title = "Immunohistochemistry of pulmonary biomarkers a perspective from members of the pulmonary pathology society",
abstract = "The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-established and powerful technique. Immunohistochemisty is readily available in pathology laboratories, is relatively easy to perform and assess, can provide clinically meaningful results very quickly, and is relatively inexpensive. Pulmonary predictive biomarkers provide results essential for timely and accurate therapeutic decision making; for patients with metastatic non-small cell lung cancer, predictive immunohistochemistry includes ALK and programmed death ligand-1 (PD-L1) (ROS1, EGFR in Europe) testing. Handling along proper methodologic lines is needed to ensure patients receive the most accurate and representative test outcomes.",
author = "Erik Thunnissen and Allen, {Timothy Craig} and Julien Adam and Aisner, {Dara L.} and Beasley, {Mary Beth} and Borczuk, {Alain C.} and Cagle, {Philip T.} and Capelozzi, {Vera Luiza} and Wendy Cooper and Hariri, {Lida P.} and Izidor Kern and Sylvie Lantuejoul and Ross Miller and Mari Mino-Kenudson and Teodora Radonic and Kirtee Raparia and Natasha Rekhtman and Sinchita Roy-Chowdhuri and Prudence Russell and Frank Schneider and Sholl, {Lynette M.} and Tsao, {Ming Sound} and Marina Vivero and Yasushi Yatabe",
note = "Funding Information: From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of S{\~a}o Paulo, S{\~a}o Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre L{\'e}on B{\'e}rard, Lyon, Universit{\'e}Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent{\textquoteright}s Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women{\textquoteright}s Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Publisher Copyright: {\textcopyright} Copyright 2018 College of American Pathologists.",
year = "2018",
month = mar,
doi = "10.5858/arpa.2017-0106-SA",
language = "English (US)",
volume = "142",
pages = "408--419",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "3",
}